Press "Enter" to skip to content

Nasal spray could fight Covid gets funding

From the Australian Associated Press

The INNA-051 nasal treatment, developed by the Australian biotech company Ena Respiratory, targets the primary site of most respiratory infections, including Covid, and activates immune defense mechanisms in the respiratory tract.

The technology could help fight coronavirus and other infections such as influenza and the common cold.

Read the rest of the story here…

Be First to Comment

Leave a Reply

DISCLAIMER: The photos used on this site are owned by the originators of the featured posts. The Matrix Gazette claims no rights or ownership of them.
The custom illustrations by Tom White however are copyrighted and owned by the Matrix Gazette and may not be used without expressed written consent.



Website Hosting and Digital Marketing by:

8th Domain Technology